INOVIO announced that the FDA has granted accelerated approval for VOCERYQ (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd), previously referred to as INO-3107, to reduce the frequency of surgery in adults with RRP…. read more.
Egetis Therapeutics AB announced that the FDA has approved Emcitate (tiratricol), a thyroid hormone receptor agonist, for the treatment of peripheral thyrotoxicosis in adults and pediatric patients with… read more.
Olezarsen can be used as an option to treat genetically confirmed familial chylomicronaemia syndrome in adults, only if response to diet and conventional triglyceride-lowering treatments (such as statins… read more.
The vast majority of TikTok accounts identified by researchers as connecting drug sellers with potential buyers in the UK remained publicly accessible 14 days after being reported for… read more.
Plozasiran can be used as an option to treat genetically confirmed familial chylomicronaemia syndrome in adults, only if response to diet and conventional triglyceride-lowering treatments (such as statins… read more.
High-nicotine vape use surged by 80% among US 18-24 year olds between 2017 and 2022, and was associated with large increases in daily vaping and nicotine dependence, finds… read more.
AbbVie announced the U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen for Skyrizi (risankizumab-rzaa) for adults with moderately to severely active Crohn’s disease (CD)…. read more.
Welcoming a new baby brings moments of joy, major milestones and significant expenses. And four in five parents say it costs too much to have a baby, according… read more.
Alexion, AstraZeneca Rare Disease’s Ultomiris (ravulizumab) has been approved in the US to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. This indication… read more.
Pharmacy Research Showcase highlights Research as part of every pharmacy career Research should be part of the routine work for every pharmacist and pharmacy technician, not a specialist… read more.
Ionis Pharmaceuticals, Inc partner, GSK plc, announced that the FDA has approved Hibsago (bepirovirsen) for the treatment of chronic hepatitis B (CHB) virus infection in combination with nucleos(t)ide… read more.
Americans with commercial insurance are generally told they have access to a strong network of mental health providers. But when researchers called providers listed in those networks, securing… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
